Regulatory News
Wednesday, November 16, 2016
BRIEF-Genexine granted FDA orphan drug designation for GX-H9 in growth hormone deficiency
* Genexine granted FDA orphan drug designation for GX-H9 in
growth hormone deficiency
Source text for Eikon:
Further company coverage:
Read more
No comments:
Post a Comment
‹
›
Home
View web version
No comments:
Post a Comment